289 related articles for article (PubMed ID: 30037746)
1. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis.
Gondim Teixeira PA; Biouichi H; Abou Arab W; Rios M; Sirveaux F; Hossu G; Blum A
Eur Radiol; 2020 Feb; 30(2):895-902. PubMed ID: 31468156
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
4. Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics.
Rhim JH; Kim JH; Moon KC; Park SW; Sohn CH; Choi SH; Yun TJ; Chang KH
Neuroradiology; 2013 Feb; 55(3):351-9. PubMed ID: 23338838
[TBL] [Abstract][Full Text] [Related]
5. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
6. [Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis].
Liu QY; Chen JY; Liang BL; Li HG; Gao M; Lin XF
Ai Zheng; 2008 Dec; 27(12):1287-92. PubMed ID: 19079995
[TBL] [Abstract][Full Text] [Related]
7. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
Fiore M; Colombo C; Radaelli S; Callegaro D; Palassini E; Barisella M; Morosi C; Baldi GG; Stacchiotti S; Casali PG; Gronchi A
Eur J Cancer; 2015 Dec; 51(18):2800-7. PubMed ID: 26602014
[TBL] [Abstract][Full Text] [Related]
8. Noncytotoxic drug therapy in children with unresectable desmoid tumors.
Lackner H; Urban C; Kerbl R; Schwinger W; Beham A
Cancer; 1997 Jul; 80(2):334-40. PubMed ID: 9217047
[TBL] [Abstract][Full Text] [Related]
9. The value of the black fiber sign on T1-weighted images for predicting stability of desmoid fibromatosis managed conservatively.
Murahashi Y; Emori M; Shimizu J; Anzai K; Tanaka T; Naka N; Tsuchie H; Nagasawa H; Miyakoshi N; Shimada Y; Yamashita T
Eur Radiol; 2020 Oct; 30(10):5768-5776. PubMed ID: 32435931
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
11. Desmoid-Type Fibromatosis of the Thorax: CT, MRI, and FDG PET Characteristics in a Large Series From a Tertiary Referral Center.
Xu H; Koo HJ; Lim S; Lee JW; Lee HN; Kim DK; Song JS; Kim MY
Medicine (Baltimore); 2015 Sep; 94(38):e1547. PubMed ID: 26402812
[TBL] [Abstract][Full Text] [Related]
12. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance imaging of desmoid-type fibromatosis: Current evaluation criteria].
Ben Haj Amor M; Ploton L; Ceugnart L; Taïeb S
Bull Cancer; 2020 Mar; 107(3):359-363. PubMed ID: 32008700
[TBL] [Abstract][Full Text] [Related]
14. Pazopanib therapy for desmoid tumors in adolescent and young adult patients.
Agresta L; Kim H; Turpin BK; Nagarajan R; Plemmons A; Szabo S; Dasgupta R; Sorger JI; Pressey JG
Pediatr Blood Cancer; 2018 Jun; 65(6):e26968. PubMed ID: 29384266
[TBL] [Abstract][Full Text] [Related]
15. Aggressive fibromatosis: MRI features with pathologic correlation.
Lee JC; Thomas JM; Phillips S; Fisher C; Moskovic E
AJR Am J Roentgenol; 2006 Jan; 186(1):247-54. PubMed ID: 16357411
[TBL] [Abstract][Full Text] [Related]
16. MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
Shimizu K; Hamada S; Sakai T; Ito S; Urakawa H; Arai E; Ikuta K; Koike H; Ishiguro N; Nishida Y
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):751-757. PubMed ID: 31448875
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen for recurrent desmoid tumor of the chest wall.
Ohashi T; Shigematsu N; Kameyama K; Kubo A
Int J Clin Oncol; 2006 Apr; 11(2):150-2. PubMed ID: 16622751
[TBL] [Abstract][Full Text] [Related]
18. MRI diagnosis and follow-up of chest wall and breast desmoid tumours in patients with a history of oncologic breast surgery and silicone implants: A pictorial report.
Grubstein A; Rapson Y; Zer A; Gadiel I; Atar E; Morgenstern S; Gutman H
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):47-53. PubMed ID: 30443994
[TBL] [Abstract][Full Text] [Related]
19. Imaging features of desmoid-type fibromatosis in the teres major muscle.
Nishio J; Aoki M; Nabeshima K; Iwasaki H; Naito M
In Vivo; 2013; 27(4):555-9. PubMed ID: 23812231
[TBL] [Abstract][Full Text] [Related]
20. Different biologic features of desmoid tumors in adult and juvenile patients: MR demonstration.
Romero JA; Kim EE; Kim CG; Chung WK; Isiklar I
J Comput Assist Tomogr; 1995; 19(5):782-7. PubMed ID: 7560326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
